Primary Carnitine Deficiency (ICD-10-CM Code: E71.41)

Name of the Condition

• Primary carnitine deficiency.

Summary

Primary carnitine deficiency is a genetic disorder that impairs the body’s ability to transport carnitine, a compound essential for fatty acid metabolism and energy production. This condition disrupts cellular energy processes, particularly affecting tissues like the heart and muscles, and may lead to systemic complications if untreated.

Causes

This disorder is caused by genetic mutations affecting the carnitine transporter protein, which is responsible for moving carnitine into cells. Inherited in an autosomal recessive pattern, it requires mutations in both copies of the relevant gene for clinical manifestation.

Risk Factors

• Family history of primary carnitine deficiency.
• Consanguinity (parents who are closely related).
• Certain ethnic populations with higher carrier rates for specific mutations.

Symptoms

• Muscle weakness or fatigue.
• Hypotonia (reduced muscle tone).
• Cardiomyopathy (heart muscle disease).
• Recurrent hypoglycemia (low blood sugar).
• Developmental delay or regression.
• Metabolic crises, including hypoketotic hypoglycemia.

Diagnosis

Diagnosis involves biochemical testing to measure carnitine levels in blood or urine, often revealing deficiencies or abnormal ratios. Confirmatory testing may include genetic analysis to identify mutations in the carnitine transporter gene.

Treatment Options

Treatment typically involves carnitine supplementation to restore normal levels and support metabolic function. Dietary management may also be recommended to optimize energy production and prevent complications.

Prognosis and Follow-Up

With early diagnosis and treatment, prognosis is generally favorable, though ongoing monitoring is necessary to manage symptoms and prevent complications. Regular follow-up with a metabolic specialist is recommended.

Complications

• Progressive muscle weakness.
• Heart failure due to cardiomyopathy.
• Severe metabolic crises.
• Developmental delays if untreated.

Lifestyle & Prevention

• Adherence to prescribed carnitine supplementation.
• Regular monitoring of carnitine levels and metabolic status.
• Avoidance of prolonged fasting or strenuous activity that may exacerbate symptoms.

When to Seek Professional Help

Seek medical attention if experiencing unexplained muscle weakness, fatigue, or signs of metabolic distress, such as confusion or low blood sugar.

Tips for Medical Coders

When coding for primary carnitine deficiency, use ICD-10-CM code E71.41. Ensure documentation supports the diagnosis, including clinical findings, biochemical testing results, and genetic confirmation if available.